Primary sarcomas of the liver are unusual neoplasms developing in adults. They constitute a heterogeneous group of neoplasms including undifferentiated embryonal sarcoma. Patients usually present with an abdominal mass and abdominal pain. Case 1: A 53-year-old woman presented with abdominal pain. Computed tomography showed an occupying mass in the right lobule and an intra-auricular multi-lobulated mass suggestive of a secondary deposit. Biopsy of the hepatic lesion revealed undifferentiated embryonal sarcoma. Despite radiotherapy and supportive measures, her overall status progressively worsened until cardiac arrest. Case 2: A 41-year-old woman presented with hepatomegaly. Abdominal imaging showed cystic lesions in the right hepatic lobule with multiple septae. The patient underwent extended right hepatectomy and a histopathological study reported high-grade undifferentiated embryonal sarcoma. Two years after surgery, a new cystic lesion in the surgical site was recorded and chemotherapy was scheduled. The lesion remained stable for three years when disease progression was observed and second-line chemotherapy was initiated. Although undifferentiated embryonal sarcoma of the liver has poor prognosis, early diagnosis is essential to increase the chances of survival. Currently, surgical resection and chemotherapy are the primary treatment modalities. 
INTRODUCTION
Primary liver sarcomas are unusual neoplasms in adulthood and constitute approximately 0.2% of all primary liver tumors. 1 They represent a heterogeneous group of neoplasms including undifferentiated embryonal sarcoma (UESL), which was first described by Stocker and Ishak 2 in 1978 as a mesenchymal tumor without any specific differentiation. Until now, few adult patients with UESL have been reported in the literature, with a slight preference for females and a mean age at diagnosis of 51. 3 Although UESL is associated with prognosis with a reported survival time of less than one year, early diagnosis is essential to increase the overall survival. 4 
CASE

Case 1
A 53-year-old female presented with abdominal distension and pain localized to the right upper abdominal quadrant radiating to the back. It was partially controlled with oral analgesia and was associated with fever. Due to pain progression, the patient was treated at the emergency department three months later for diaphoresis and dyspnea on exertion associated with right chest wall pain that irradiated to ipsilateral shoulder. On examination, the patient presented with abdominal distension and a painful palpable mass in the right hypochondrium. Laboratory studies indicated leukocytosis and neutrophilia, while the liver tests were normal. Multiphase contrast-enhanced computed tomography scan showed a liver with an occu-
Fig. 1.
Computed tomography with intravenous contrast showing a (A) right liver lobule with a 20 cm-sized hypodense lesion (arrow) with irregular borders, a few septa, and centripetal reinforcement without any intra or extrahepatic biliary tract dilation.
(B) The heart was augmented in size and the left auricle showed a 39 mm-sized hypodense mass with multi-lobulated borders leading to filling defect (black arrow). In addition, a lytic lesion in the fourth right costal arch was documented (white arrow), both of which suggesting secondary deposits. Due to disease recurrence, chemotherapy with doxorubicin and isophosphamide was scheduled; however, only three cycles were administered due to hematological toxicity manifesting as neutropenia and fever. The lesion remained stable until three years when an increase in size and appearance of new lesions suggesting disease progression were observed (Fig. 3) . After five years from the initial diagnosis, the patient was scheduled to receive che-
Fig. 2.
Computed tomography with intravenous contrast that showed a (A) liver enlargement due to the presence of a 26 cm-sized cystic lesion with multiple thick septa (arrow). The lesion showed reinforcement with contrast material without evidence of solid tissue, in addition to compression and displacement of structures in the midline towards the left. Abdominal ultrasound (B) showed a previously described lesion with inner echoes and multiple septa, and compressed intrahepatic vascular structures including portal vein (arrow).
Fig. 3.
Computed tomography with intravenous contrast (A) after extended right hepatectomy with post-surgical changes, the left lobule showed homogeneous density and regular form as well as an intrahepatic biliary tract with preserved caliber. Two years later (B) there was a 10 mm-sized hypodense heterogeneous lesion in the anterior portion of the left portal vein without occasional filling defects. The remainder of the liver parenchyma showed no changes. Five years after the initial diagnosis (C) the lesion documented previously showed an increase in size to 30 mm, suggesting disease progression.
motherapy with gemcitabine and docetaxel.
DISCUSSION
Patients with UESL usually present with an abdominal mass and abdominal pain, associated with anorexia, lethargy, and weight loss. Other symptoms may include nausea, vomiting, constipation, and respiratory distress secondary to compression caused by the tumor. 5 Spontaneous rupture of the neoplasm has also been documented. 6 Liver test results and neoplastic markers are usually normal. In patients with associated hemorrhage and necrosis inside the tumor, fever and increased levels of systemic inflammatory markers including C reactive protein, erythrocyte sedimentation rate, and leukocytosis, may be present. and actin filaments in the cytoplasm. 13 Lauwers et al. Cystic lesions show low signal intensity on T1-weighted MRI and high signal intensity on T2-weighted images suggesting water content. Furthermore, areas with high signal intensity on T1-weighted images and low signal intensity on T2-weighted images suggest hemorrhage. 17, 18 Surgical resection and chemotherapy are the primary treatment modalities for UESL, and chemotherapy is based on a combination of vincristine, actinomycin, ifosfamide and doxorubicin. 19 In the absence of complete tumor resection at the time of diagnosis, definitive surgery may be indicated after neoadjuvant chemotherapy. The current 1-year and 2-year survival rates in patients with UESL are 61% and 55%, respectively, with a median survival of 29 months. However, recurrence is a common scenario reported in 32% of the cases with complete resection and adjuvant chemotherapy after a median follow-up of 28 months. 20 
